BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » Rachelle H.B. Fishman

Articles by Rachelle H.B. Fishman

Non-contact devices deliver more efficient healthcare

July 9, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel — What new medical device and biotechnology parameters are bolded as the big biomedical and healthcare buyers, scan the flow of hundreds of business plans and proposals from aspiring biomed inventors, entrepreneurs, companies? (Medical Device Daily)
Read More

Cleveland Clinic attracts Israeli companies with its smart money

July 1, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel – Israel's annual life science industry conference ILSI-Biomed 2010, held here in mid-June, selected 40 of Israel's 400-something startup companies to show off their novel inventions, attract investors and strategic partners, and share war stories. (Medical Device Daily)
Read More

Conference record crowd sees device firms share spotlight

June 30, 2010
By Rachelle H.B. Fishman
TEL AVIV, Israel – A record 7,000 participants, including 1,000 from more than 40 other countries, gathered for the 9th annual Israel Life Science Industry ILSI-Biomed conference and Kenes exhibition here in mid-June. (Medical Device Daily)
Read More

BioLineRx Bringing In $9M For Prodrug Pipeline Work

Sep. 28, 2005
By Rachelle H.B. Fishman

Israeli Chief Scientist Supports Hybrid R&D Biotech Institutes

Aug. 3, 2005
By Rachelle H.B. Fishman

Protalix Series C: $5.3M For Gaucher's Disease Product

July 27, 2005
By Rachelle H.B. Fishman

Israel Sends Delegates To BIO 2005 Annual Convention

June 29, 2005
By Rachelle H.B. Fishman

Bio-Tech Israel 2005 Meeting Focuses On 'Holistic' Attack

June 8, 2005
By Rachelle H.B. Fishman

Intec Pharma Gets New CEO, Plans 'Accordion Pill' Program

May 18, 2005
By Rachelle H.B. Fishman

Can Tissera Revive Plunging Stock Under New Leadership?

April 20, 2005
By Rachelle H.B. Fishman
Previous 1 2 3 4 5 6 7 8 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing